What is NDC 68682-582?

68682-582 is the product NDC for Bupropion Hydrobromide, Bupropion hydrobromide 522 mg/1 tablet, extended release, listed with the FDA by Oceanside Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.

Oceanside Pharmaceuticals, NDC labeler code 68682. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bupropion Hydrobromide?

2 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bupropion Hydrobromide NDC 68682-582

NDC codes

FDA NDC Directory

Product NDC (as listed)68682-582Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68682-0582Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68682-582-30	6868205823068682058230	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-582-30)Marketed from Jun 29, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bupropion Hydrobromide
Generic name (nonproprietary): bupropion hydrobromide
Active ingredients: Bupropion hydrobromide — 522 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Oceanside PharmaceuticalsNDC labeler code 68682
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 022108
Marketing start: Jun 29, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Dopamine Uptake Inhibitors (Mechanism)Increased Dopamine Activity (Physiologic effect)Increased Norepinephrine Activity (Physiologic effect)Norepinephrine Uptake Inhibitors (Mechanism)
Identifiers: Product ID 68682-582_361893cf-be64-4b2c-a70e-e3ba68e69309SPL ID 361893cf-be64-4b2c-a70e-e3ba68e69309SPL set ID 3ec04240-baef-44d7-8d73-a181171eec43RxCUI 993550, 993567, 993681UNII E70G3G5863
Pharmacologic class: Aminoketone

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468682058230 followed by a unit qualifier and the quantity

Package 68682-0582-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 1, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Bupropion Hydrobromide Extended-Release Tablets are an aminoketone antidepressant, indicated for the treatment of major depressive disorder (MDD) and seasonal affective disorder (SAD). Periodically reevaluate long-term usefulness for the individual patient. ( 1 ) 1.1 Major Depressive Disorder Bupropion Hydrobromide Extended-Release Tablets are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). The efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with MDD. The efficacy of the sustained-release f…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68682-582

What is NDC 68682-582?: 68682-582 is the product NDC for Bupropion Hydrobromide, Bupropion hydrobromide 522 mg/1 tablet, extended release, listed with the FDA by Oceanside Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bupropion Hydrobromide.
What is the active ingredient?: Bupropion hydrobromide.
Who is the labeler?: Oceanside Pharmaceuticals, NDC labeler code 68682. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bupropion Hydrobromide?: 2 other product NDCs are listed under this name. See all Bupropion Hydrobromide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Bupropion Hydrobromide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Bupropion Hydrobromide	Bupropion hydrobromide 174 mg/1	Tablet, Extended releaseOral	Oceanside Pharmaceuticals	68682-580	68682-0580-30
Bupropion Hydrobromide	Bupropion hydrobromide 348 mg/1	Tablet, Extended releaseOral	Oceanside Pharmaceuticals	68682-581	68682-0581-30

Other NDCs under NDA 022108

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 022108
Product	Strength	Form · route	Labeler	Product NDC
Aplenzinbupropion hydrobromide	Bupropion hydrobromide 174 mg/1	Tablet, Extended releaseOral	Bausch Health US, LLC	0187-5810
Aplenzinbupropion hydrobromide	Bupropion hydrobromide 348 mg/1	Tablet, Extended releaseOral	Bausch Health US, LLC	0187-5811
Aplenzinbupropion hydrobromide	Bupropion hydrobromide 522 mg/1	Tablet, Extended releaseOral	Bausch Health US, LLC	0187-5812
Bupropion Hydrobromide	Bupropion hydrobromide 174 mg/1	Tablet, Extended releaseOral	Oceanside Pharmaceuticals	68682-580
Bupropion Hydrobromide	Bupropion hydrobromide 348 mg/1	Tablet, Extended releaseOral	Oceanside Pharmaceuticals	68682-581